Clinical Trial Update: Prevention of Graft Rejection in Hematopoietic Stem Cell Transplant (HSCT) Recipients [EARLY_Phase 1]

View source ↗

Summary

An early-phase Phase 1 clinical trial aims to prevent graft rejection in hematopoietic stem cell transplant recipients and is currently recruiting. The study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft Failure

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Hematopoietic Stem Cell Transplantation, Graft Failure | EARLY_Phase 1 | Status: RECRUITING